No Data
No Data
Abeona Therapeutics Price Target Maintained With a $18.00/Share by Cantor Fitzgerald
Abeona Therapeutics Announces Participation in Upcoming Investor Conferences
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Express News | Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Analysts Conflicted on These Healthcare Names: Abeona Therapeutics (ABEO), Cyclacel Pharmaceuticals (CYCC) and Cardinal Health (CAH)
H.C. Wainwright Maintains Abeona Therapeutics(ABEO.US) With Buy Rating, Maintains Target Price $15
H.C. Wainwright analyst Ram Selvaraju maintains $Abeona Therapeutics(ABEO.US)$ with a buy rating, and maintains the target price at $15.According to TipRanks data, the analyst has a success rate of 40